NEW

IAHCSMM Announces Board of Director Election Results

The International Association of Healthcare Central Service Materiel Management (IAHCSMM) announced the election results for four board of director positions.

Medtronic Recalls Valiant Navion Thoracic Stent Graft System

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Ambu Launches New Single-Use Cystoscope

Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, introduced a new single-use cystoscope. The Ambu aScope 4 Cysto will give urologists immediate access to a single-use cystoscope that can be used for procedures such as bladder cancer surveillance, stent removal and other common cystoscopy procedures.

Built on more than 10 years of single-use endoscopy experience, the launch of the aScope 4 Cysto enables Ambu to enter a large new market segment. Its new cystoscope will provide urologists a way to better manage their schedules and be more productive without worrying about device deterioration and other issues such as availability, reprocessing and costly repairs.

“This is a game changer,” said Juan Jose Gonzalez, CEO of Ambu S/A, headquartered in Ballerup, Denmark. “Urologists will now have immediate access to a high-quality scope that eliminates reprocessing and repairs. A urologist opens the package and immediately has a new scope offering peak performance with full articulation. They don’t have to wait and worry whether a scope will be available or whether it will work properly.”

The aScope 4 Cysto enables organizations to reduce costs on cleaning supplies, maintenance and repairs (and the associated long-term service contracts). It improves workflow and is portable, which makes it easier for doctors to deal with in-house consult procedures.

“The Cystoscope is a multi-purpose tool used by all urologists; therefore, we are excited to introduce the aScope 4 Cysto which affords urologists excellent imaging, smooth maneuverability, and consistent performance every time,” said Jens Kemp, Ambu Inc.’s vice president of U.S. marketing. “It is a perfect solution for both flexible cystoscopies performed in the outpatient clinic as well as inpatient consults on the ward and ER.”

Ambu, already the world leader in single-use scopes, is ramping up manufacturing to provide a single-use endoscope solution in multiple flexible endoscopy segments, including Pulmonology, ENT, Urology and Gastroenterology. In conjunction with the aScope 4 Cysto and additional endoscopes coming to market, Ambu also recently introduced its aView 2 Advance, a state-of-the-art, high-definition monitor. This mobile platform can be used by pulmonologists, ENTs, urologists, thoracic surgeons, intensive care specialists and other specialists who perform millions of endoscopy procedures each year.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X